Apple defeats Alivecor IDB to block the imports of US smartwatch. UU. In the attraction of the United States

Apple convinced a Court of Appeals of the United States on Friday to maintain its victory against the manufacturer of relief medical devices in a patent dispute that could have led to an import prohibition of Apple Watches.

The United States Court of Appeals for the Federal Circuit affirmedOpen a new tab The disability of the monitoring patents of the relief rate that the company had accused Apple of Infringir, denying the decision of a commercial court in the United States that Apple had violated the rights of Alivecor.

An Alivecor spokesman said the company was “deeply disappointed” by decisions and is exploring “all available legal options, including potential appeals.” The spokesman said that the decision does not affect the ongoing business of Alivecor.

An Apple spokesman said his teams “have worked tirelessly for many years to develop leaders of health, well -being and security in the industry that significantly affect users' lives.”

Alivecor, based in Mountain View, California, sought a ban on Apple Watch imports in the United States International Trade Commission in 2021.

He accused the technological giant of violating three patents related to KardiaBand de Alivecor, an Apple Watch accessory that monitors the heart rate of a user, detects irregularities and performs an electrocardiogram to identify heart problems such as atrial fibrillation.

Alivecor told the commission that Apple copied its technology from the 4 Apple Watches series and expelled it from the market causing the iOS operating system to be incompatible with the Kardiaband.

The trial and appeals Board of the United States Patent Office invalidated Patents at Apple's request in 2022. The ITC determined weeks after Alivecor would be entitled to an import prohibition of violating Apple's watches if the patents were valid, but stopped the prohibition while the federal circuit considered appeals.

The Federal Circuit agreed with Apple on Friday that Alivecor patents were not valid and dismissed the ITC case.

Apple was beaten with a separate import prohibition of some Apple watches in 2023 as part of a patent dispute with MasimoOpen a new tab on blood oxygen monitoring technology. Apple has appealed the decision and resumed the sale of watches after eliminating technology.

Alivecor cases are relief inc v. International Trade Commission, Court of Appeals of the United States for the Federal Circuit, No. 23-1509 and Alivecor Inc v. Apple Inc, United States Court of Appeals for the Federal Circuit, No. 23-1512.